Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates

著者: Wang, Yi, Fang, Sui, Wu, Yan, Cheng, Xi, Zhang, Lei-ke, Shen, Xu-rui, Li, Shuang-qu, Xu, Jian-rong, Shang, Wei-juan, Gao, Zhao-bing, Xia, Bing-qing
出版年 Acta Pharmacol Sin (2021)

Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension

著者: Zhang, Lei-Ke, Sun, Yuan, Zeng, Haolong, Wang, Qingxing, Jiang, Xiaming, Shang, Wei-Juan, Wu, Yan, Li, Shufen, Zhang, Yu-Lan, Hao, Zhao-Nian, Chen, Hongbo, Jin, Runming, Liu, Wei, Li, Hao, Peng, Ke, Xiao, Gengfu
出版年 Cell Discov (2020)

Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension

著者: Zhang, Lei-Ke, Sun, Yuan, Zeng, Haolong, Wang, Qingxing, Jiang, Xiaming, Shang, Wei-Juan, Wu, Yan, Li, Shufen, Zhang, Yu-Lan, Hao, Zhao-Nian, Chen, Hongbo, Jin, Runming, Liu, Wei, Li, Hao, Peng, Ke, Xiao, Gengfu
出版年 Cell Discov (2021)

A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors

著者: Ren, Peng-xuan, Shang, Wei-juan, Yin, Wan-chao, Ge, Huan, Wang, Lin, Zhang, Xiang-lei, Li, Bing-qian, Li, Hong-lin, Xu, Ye-chun, Xu, Eric H., Jiang, Hua-liang, Zhu, Li-li, Zhang, Lei-ke, Bai, Fang
出版年 Acta Pharmacol Sin (2021)

Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

著者: Su, Hai-xia, Yao, Sheng, Zhao, Wen-feng, Li, Min-jun, Liu, Jia, Shang, Wei-juan, Xie, Hang, Ke, Chang-qiang, Hu, Hang-chen, Gao, Mei-na, Yu, Kun-qian, Liu, Hong, Shen, Jing-shan, Tang, Wei, Zhang, Lei-ke, Xiao, Geng-fu, Ni, Li, Wang, Dao-wen, Zuo, Jian-ping, Jiang, Hua-liang, Bai, Fang, Wu, Yan, Ye, Yang, Xu, Ye-chun
出版年 Acta Pharmacol Sin (2020)